V Kolek Selected Research

V Kolek Research Topics

Disease

11	Sarcoidosis (Schaumann Disease) 11/2011 - 09/2000
8	Neoplasms (Cancer) 01/2018 - 03/2000
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2000
5	Pulmonary Sarcoidosis 11/2011 - 09/2000
3	Neoplasm Metastasis (Metastasis) 01/2019 - 04/2007
2	Adenocarcinoma of Lung 01/2021 - 01/2018
2	Lung Neoplasms (Lung Cancer) 08/2017 - 04/2007
2	Carcinoma (Carcinomatosis) 04/2007 - 06/2004
2	Pneumonia (Pneumonitis) 06/2003 - 04/2001
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Silicosis 09/2018
1	Carcinogenesis 01/2018
1	Healthcare-Associated Pneumonia 11/2017
1	Pathologic Constriction (Stenosis) 08/2017
1	Idiopathic Pulmonary Fibrosis 08/2017
1	Radiation Pneumonitis 08/2017
1	Rhinitis 01/2016
1	Asthma (Bronchial Asthma) 01/2016
1	Inflammation (Inflammations) 11/2011
1	Granuloma 11/2011
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2008
1	Lymphatic Metastasis 04/2007
1	Pulmonary Atelectasis 02/2007
1	Pleural Effusion (Pleural Effusions) 02/2007
1	Pancreatitis 02/2007
1	Hypoxia (Hypoxemia) 02/2007
1	Chronic Pancreatitis 02/2007
1	Necrosis 02/2005
1	Disease Progression 11/2002
1	Chronic Granulomatous Disease 09/2001

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 11/2011 - 11/2002
4	Proteins (Proteins, Gene)FDA Link 11/2011 - 09/2001
4	ChemokinesIBA 11/2011 - 09/2000
3	LigandsIBA 03/2009 - 09/2000
2	CC ChemokinesIBA 03/2009 - 11/2002
2	Matrix Metalloproteinases (MMPs)IBA 03/2009 - 01/2007
2	Chemokine CCL5IBA 11/2002 - 09/2000
1	tacedinaline (CI 994)IBA 01/2021
1	Silicon Dioxide (Silica)FDA LinkGeneric 09/2018
1	Therapeutic UsesIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	FilaminsIBA 01/2016
1	Microfilament Proteins (Actin Binding Proteins)IBA 01/2016
1	PlatinumIBA 01/2016
1	InterferonsIBA 11/2011
1	Transcription Factors (Transcription Factor)IBA 11/2011
1	CXCR ReceptorsIBA 11/2011
1	AnnexinsIBA 09/2011
1	ImmunosorbentsIBA 03/2009
1	EnzymesIBA 03/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2009
1	macrophage stimulating proteinIBA 03/2009
1	Macrophage Migration-Inhibitory FactorsIBA 03/2009
1	CytokinesIBA 03/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2008
1	Complement Receptors (Complement Receptor)IBA 01/2008
1	Amylases FDA Link 02/2007
1	Transfer Factor (Factor, Transfer)IBA 02/2007
1	MetalsIBA 01/2007
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2007
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2007
1	Matrix Metalloproteinase 11IBA 01/2007
1	Lymphotoxin-alpha (Lymphotoxin)IBA 02/2005
1	HLA-DRB1 Chains (HLA DRB1)IBA 02/2005
1	HLA-DRB1*07 antigenIBA 02/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2005
1	Cysteine (L-Cysteine)FDA Link 11/2002
1	Chemokine CCL3IBA 11/2002
1	LatexIBA 09/2001
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2001
1	HLA-DR Antigens (HLA-DR)IBA 09/2001
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2001
1	Petroleum (Crude Oil)IBA 04/2001
1	HydrocarbonsIBA 04/2001
1	Isoleucine (L-Isoleucine)FDA Link 09/2000
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 09/2000
1	CCR ReceptorsIBA 09/2000
1	Valine (L-Valine)FDA Link 09/2000
1	Cytostatic AgentsIBA 03/2000

Therapy/Procedure

4	Therapeutics 04/2007 - 09/2000
3	Drug Therapy (Chemotherapy) 01/2013 - 04/2007
3	Neoadjuvant Therapy 08/2011 - 06/2004
1	Nephrectomy 01/2019
1	Critical Care (Surgical Intensive Care) 11/2017
1	Brachytherapy 08/2017
1	Radiotherapy 08/2017
1	Precision Medicine 01/2016
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016
1	Adjuvant Chemotherapy 01/2013
1	Induction Chemotherapy 04/2007
1	Operative Surgical Procedures 06/2004
1	Lymph Node Excision (Lymph Node Dissection) 01/2000